Ngb Laboratories Profile
Key Indicators
- Authorised Capital ₹ 12.00 Cr
- Paid Up Capital ₹ 11.75 Cr
- Company Age 11 Year, 3 Days
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 31.70 Cr
- Revenue Growth 144.05%
- Profit Growth -60.94%
- Ebitda -142.25%
- Net Worth -93.59%
- Total Assets -70.64%
About Ngb Laboratories
Ngb Laboratories Private Limited (NLPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 17 February 2014 and has a history of 11 years. Its registered office is in Surat, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 12.00 Cr and a paid-up capital of Rs 11.75 Cr.
The company has closed loans amounting to ₹31.70 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Ngb Laboratories Private Limited India is Ankita Bhikadia as COMPANY SECRETARY. Harishkumar Bachkaniwala, Manishkumar Bachkaniwala, Dharmesh Kharwar, and Two other members serve as directors at the Company.
Company Details
- Location
Surat, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100GJ2014PTC078771
- Company No.
078771
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Feb 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Ngb Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ankita Bhikadia  | Company Secretary | 09-Jun-2023 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Harishkumar Bachkaniwala | Director | 17-Feb-2014 | Current |
| Manishkumar Bachkaniwala | Director | 17-Feb-2014 | Current |
| Dharmesh Kharwar | Director | 04-Apr-2019 | Current |
| Jasmin Bachkaniwala | Director | 19-Feb-2014 | Current |
| Mansukhlal Bachkaniwala | Director | 19-Feb-2014 | Current |
Financial Performance of Ngb Laboratories.
Ngb Laboratories Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 144.05% increase. The company also saw a substantial fall in profitability, with a 60.94% decrease in profit. The company's net worth observed a substantial decline by a decrease of 93.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ngb Laboratories?
In 2022, Ngb Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Zodiac-Jrd-Mkj LimitedDharmesh Kharwar is a mutual person
Entod Pharmaceuticals LimitedDharmesh Kharwar is a mutual person
- Robin Life Sciences Private Limited
Harishkumar Bachkaniwala and Mansukhlal Bachkaniwala are mutual person
Charges (Loans)
₹0
₹31.70 Cr
Charges Breakdown by Lending Institutions
- Others : 28.35 Cr
- The Sutex Co-Operative Bank Ltd : 3.35 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Jul 2020 | Others | ₹1.00 Cr | Satisfied |
| 20 Dec 2017 | Others | ₹8.25 Cr | Satisfied |
| 03 Mar 2015 | The Sutex Co-Operative Bank Ltd | ₹2.35 Cr | Satisfied |
| 03 Mar 2015 | The Sutex Co-Operative Bank Ltd | ₹1.00 Cr | Satisfied |
| 23 Feb 2015 | Others | ₹19.10 Cr | Satisfied |
How Many Employees Work at Ngb Laboratories?
Ngb Laboratories has a workforce of 3 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ngb Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ngb Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
